ENDRA Life Sciences Inc (NDRA)
ENDRA Life Sciences Inc. is a healthcare equipment and supplies company focused on developing technologies that enhance clinical diagnostic ultrasound. Its work centers on thermo-acoustic enhanced ultrasound, which uses a pulsed radio frequency energy source to send energy deep into tissue and generate ultrasonic waves for high-contrast imaging. The company says this technology is being developed for applications including non-alcoholic fatty liver disease, tissue composition assessment, temperature monitoring, vascular imaging, and tissue perfusion. Incorporated in 2007, ENDRA Life Sciences is based in Ann Arbor, Michigan. The listed security is common stock on NASDAQ under the symbol NDRA.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NDRA
|
$5.78
|
5.1% Upside
|
Fair
|
$25
|
354.5% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
-0.9x
|
3.7x
|
—
|
6.281 M
|
6.804 M
|
6.8%
|
94.4%
|
-49.5
|
—
|
68.6%
|
